Health state utilities associated with treatment for transfusion-dependent β-thalassemia

OBJECTIVES: Transfusion-dependent β-thalassemia (TDT) is a genetic disease that affects production of red blood cells. Conventional treatment involves regular red blood cell transfusions and iron chelation, which has a substantial impact on quality of life. While potentially curative, allogeneic hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Matza, Louis S., Paramore, L. Clark, Stewart, Katie D., Karn, Hayley, Jobanputra, Minesh, Dietz, Andrew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188724/
https://www.ncbi.nlm.nih.gov/pubmed/31828456
http://dx.doi.org/10.1007/s10198-019-01136-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188724/
https://www.ncbi.nlm.nih.gov/pubmed/31828456
http://dx.doi.org/10.1007/s10198-019-01136-0

Ejemplares similares